Elsevier: Goodman & Snyder: Differential Diagnosis for Physical Therapists Screening for Referral, 5th Edition - Chapter 11 Screening for Endocrine and Metabolic Disease

Chapter 11 Screening for Endocrine and Metabolic Disease

  1. Schnetzler KA: Acute carpal tunnel syndrome. J Am Acad Orthop Surg 16:276–282, 2008. Medline abstracts
  2. Bickel KD: Carpal tunnel syndrome. J Hand Surg 35A:147–152, 2010.
  3. Palmer KT: Carpal tunnel syndrome and its relation to occupation: a systematic literature review. Occup Med 57:57–66, 2007.
  4. Lozano-Calderon S: The quality and strength of evidence for etiology: example of carpal tunnel syndrome. J Hand Surg 33A(4):525–538, 2008.
  5. Phalen GS: The carpal tunnel syndrome: seventeen years’ experience in diagnosis and treatment of six hundred and fifty-four hands. J Bone Joint Surg 48A(2):211–228, 1966.
  6. Grossman LA, Kaplan HJ, Ownby FD: Carpal tunnel syndrome: initial manifestation of systemic disease. JAMA 176:259–261, 1961. Medline abstracts
  7. Wluka AE, Cicuttini FM, Spector TD: Menopause, oestrogens, and arthritis. Maturitas 35(3):183–189, 2000. Medline abstracts
  8. Ferry S, Hannaford P, Warskyj M, et al: Carpal tunnel syndrome: a nested case-control study of risk factors in women. Am J Epidemiol 151(6):566–574, 2000. Medline abstracts
  9. Michlovitz S: Conservative interventions for carpal tunnel syndrome. J Orthop Sports Phys Ther 34(10):591–598, 2004.
  10. Grokoest AW, Demartini FE: Systemic disease and carpal tunnel syndrome. JAMA 155:635–637, 1954.
  11. Katz JN: Clinical practice: carpal tunnel syndrome. N Engl J Med 346:1807, 2002.
  12. McNab T, Khandwala H: Acromegaly as an endocrine form of myopathy: a case report and review of the literature. Endocr Prac 11(1):18–22, 2005. Available online at www.medscape.com/viewarticle/501408. Accessed January 21, 2011.
  13. Rothschild B: Hyperostosis associated with hip surgery? J Musculoskel Med 21(5), 2004.
  14. Holcomb S: Confronting Cushing’s syndrome. Nursing 2005, 35(9):32–36, 2005.
  15. Holcomb SS: Detecting thyroid disease. Nursing 2005 35(10):S4-S9, 2005.
  16. Boissonnault WG, Koopmeiners MB: Medical history profile: orthopaedic physical therapy outpatients. J Orthop Sports Phys Ther 20(1):2–10, 1994. Medline abstracts
  17. President and Fellows of Harvard College, Harvard Medical School: Thyroid diseases—a special health report. Harvard Health Newsletter, 2004.
  18. Trivalle C, Doucet J, Chassagne P, et al: Differences in the signs and symptoms of hypothyroidism in older and younger patients. J Am Geriatr Soc 1(44):50–53, 1996.
  19. Lowe JC, Honeyman-Lowe G: The metabolic treatment of fibromyalgia, Lafayette, CO, 2000, McDowell Health Science Books.
  20. Lowe JC, Lowe G: Facilitating the decrease in fibromyalgia pain during metabolic rehabilitation: an essential role for soft tissue therapies. J Bodywork Movement Ther 2(4):208–217, 1998.
  21. Lowe JC, Reichman AJ, Honeyman GS, et al: Thyroid status of fibromyalgia patients. Clin Bull Myofascial Ther 3(1):47–53, 1998a.
  22. Lowe JC, Reichman AJ, Yellin BA: A case-control study of metabolic therapy for fibromyalgia: long term follow-up comparison of treated and untreated patients. Clin Bull Myofascial Ther 3(1):65–79, 1998b.
  23. Geenen R, Jacobs JW, Bijlsma JW: Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 28(2):389–404, 2002. Medline abstracts
  24. Garrison RL, Breeding PC: A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 61(2):182–189, 2003. Medline abstracts
  25. An anti-nuclear shield for your thyroid. Johns Hopkins Med Lett 14(8):5–7, 2002.
  26. Gagel RF, Goepfert H, Callender DL: Changing concepts in the pathogenesis and management of thyroid carcinoma. CA Cancer J Clin 46(5):261–283, 1996. Medline abstracts
  27. Strewler G: Primary hyperparathyroidism does not progress in most patients. JAMA (293):1772–1779, 2005. Medline abstracts
  28. Utiger R: The physician’s perspective. NEJM Health News 9(1):5, 2003.
  29. Morbidity and Mortality Weekly Report: November is American Diabetes Month. MMWR 59(42):1361, 2010.
  30. Burrows NR: Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes in the United States and Puerto Rico. MMWR 59(42):1361–1366, 2010. Medline abstracts
  31. New York Academy of Sciences: Is Alzheimer’s disease type 3 diabetes? Webinar presented by the Biochemical Pharmacology Discussion Group and the American Chemical Society. Oct. 27, 2009. Available online at http://www.nyas.org/events/WebinarDetail.aspx?cid=25aebb2b-0529-4cc1-92b0-c38c38b3d34f. Accessed March 3, 2011.
  32. Wood L, Setter SM: Type 3 Diabetes: brain diabetes? US Pharm 35(5):36–41, 2010. Available online at http://www.uspharmacist.com/content/d/feature/c/20754/. Accessed March 3, 2011.
  33. Centers for Disease Control and Prevention: Diabetes: National Diabetes Fact Sheet for the United States, 2010. Available online at http://www.cdc.gov/diabetes/statistics/index.htm. Accessed January 21, 2011.
  34. Boyle JP: Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 8:29, 2010.
  35. Centers for Disease Control and Prevention (CDC): Number of Americans with diabetes projected to double or triple by 2050. Older, more diverse populations and longer lifespans contribute to increase. October 22, 2010. Available online at http://www.cdc.gov/media/pressrel/2010/r101022.html. Accessed March 3, 2011.
  36. American Diabetes Association: Standards of medical care in diabetes—2010. Diabetes Care 33(suppl 1): S11-S61, 2010.
  37. Norris SL, Zhang X, Avenell A, et al: Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev 2:CD005270, April 18, 2005.
  38. US Renal Data System: USRDS 2009 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD, 2009, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
  39. Katon WJ, Rutter C, Simon G, et al: The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28(11):2668–2672, 2005. Medline abstracts
  40. Ciechanowski P, Russo J, Katon W, et al: Where is the patient? The association of psychosocial factors and missed primary care appointments in patients with diabetes. Gen Hosp Psychiatry 28(1):9–17, 2006. Medline abstracts
  41. Katon W, Cantrell CR, Sokol MC, et al: Impact of antidepressant drug adherence on comorbid medication use and resource utilization. Arch Intern Med 165(21):2497–2503, 2005. Medline abstracts
  42. Barclay L: Modifiable risk factors may be linked to risk of developing diabetic neuropathy. N Engl J Med 352:341–350, 408–409, 2005. Available online at http://www.medscape.com/viewarticle/498185. Accessed January 11, 2011. Medline abstracts
  43. Tesfaye S, Chaturvedi N, Eaton SE, et al: Vascular risk factors and diabetic neuropathy. N Engl J Med 352(4):341–350, 2005.
  44. Said G: Diabetic neuropathy—a review. Nat Clin Pract Neurol 3(6):331–340, 2007. Available online at: http://www.medscape.com/viewarticle/558574. Accessed Dec. 13, 2010. Medline abstracts
  45. Cagliero E, Apruzzese W, Perlmutter GS: Watch for hand, shoulder disorders in patients with diabetes. Am J Med 112:487–490, 2002. Medline abstracts
  46. Cullen A, Oflouglu O, Donthineni R: Neuropathic arthropathy of the shoulder, Charcot shoulder. Medscape 7(1), 2005. Available online at www.medscape.com/viewarticle/496650). Accessed on January 21, 2011.
  47. Scarborough P: Diabetes care: tests and measures for the foot and lower extremity. Acute Care Perspectives 11(4):1–6, 2002.
  48. Boulton A: Treatment of symptomatic diabetic neuropathy. Diabetes Metab Res Rev 19(Suppl 1): S16–S21, 2003. Medline abstracts
  49. Kelly J: Manipulation for frozen shoulder. J Musculoskel Med, 20(2):58, 2003.
  50. Mukhtar Q, Pan L, Jack L et al: Prevalence of receiving multiple preventive care services among adults with diabetes—United States, 2002–2004. MMWR 54(44):1130, 2005.
  51. Agency for Healthcare Research and Quality (AHRQ): Diagnosis and management of type 2 diabetes mellitus in adults. Updated by ECRI Institute, 2010. Available online at http://guideline.gov/content.aspx?f=rss&id=24137. Accessed March 2, 2011.
  52. Colberg SR, Walsh J: Pumping insulin during exercise. Phys Sports Med 30(4), April 2002. Available online at http://www.physsportsmed.com/index.php?article=255. Accessed January 20, 2011.
  53. Auber G: Taking the heat off: how to manage heat injuries. Nursing 2004 34(7):50–52, 2004. Medline abstracts
  54. Appel SJ: Sizing up patients for metabolic syndrome. Nursing 2005 35(12):20–21, 2005.
  55. Lorenzo C: The National Cholesterol Education Program—Adult Treatment Panel III, International Diabetes Federation and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30(1):8–13, 2007. Medline abstracts
  56. Alberti KG, Eckel RH, Grundy SM, et al: Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645, 2009. Medline abstracts
  57. Olatunbosun ST: Insulin resistance, eMedicine. Updated 5/16/10. Available online at http://emedicine.medscape.com/article/122501-print. Accessed Sept. 15, 2010.
  58. Rosenzweig JL: Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93(10):3671–3689, 2008. Medline abstracts
  59. Chen L, Schumacher R: Gout and gout mimickers: 20 clinical pearls. J Musculoskel Med 20(5):254–258, 2003.
  60. Kurakula PC, Keenan RT: Diagnosis and management of gout: an update. J Musculoskel Med 27(suppl): S13-S19, 2010.
  61. Barclay L, Lie D: Dietary risk factors for gout clarified. Medscape Medical News March 10, 2004. Available online at http://www.medscape.com/viewarticle/471444. Accessed January 21, 2011.
  62. Choi HK: A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 22(2):165–172, 2010. Medline abstracts
  63. Choi HK: Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281, 2004. Medline abstracts
  64. Wiese W, Sanders LS, Wortmann RL: Gout: effective strategies for acute and long-term control. J Musculoskel Med 21(10):510–519, 2004.
  65. Stevens S, Edwards C: Recognizing and managing hemochromatosis and hemiarthropathy. J Musculoskel Med 21(4):212–225, 2004.
  66. Agency for Healthcare Research & Quality (AHRQ): Screening and risk assessment for osteoporosis in postmenopausal women. Revised 2011. Available online at http://guideline.gov/syntheses/synthesis.aspx?f=rss&id=25304. Alternate website: http://www.guideline.gov. Accessed March 2, 2011.
  67. Edwards BJ, Brooks ER, Langman CB: Osteoporosis screening of postmenopausal women in the primary care setting; a case-based approach. Gend Med 1(2):70–85, 2004. Medline abstracts
  68. Feldstein AC, Nichols GA, Elmer JP, et al: Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg 85A(12):2294–2302, 2003.
  69. Dipaola CP: Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis. Spine J 9(7):537–544, 2009. Medline abstracts
  70. Focus on Healthy Aging: Expert panel urges mass screening for osteoporosis, older women. Mt Sinai School Med 6(1):2, 2003.
  71. Black DM, Steinbuch M, Palermo L, et al: An assessment tool for predicting fracture risk in postmenopausal women. Osteoporosis Int 12(7):519–528, 2001.
  72. Maricic M, Gluck O: Osteoporosis: 20 clinical pearls. J Musculoskel Med 20(11):508–512, 2003.
  73. Bones are big news. Johns Hopkins Med Lett Health After 50 17(1):4–5, 2005.
  74. Kiebzak G, Beinart G, Perser K, et al: Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162(19):2217–2222, 2002. Medline abstracts
  75. Simmons G: Far Eastern osteoporosis study, Hong Kong, 1996, The Gordon Simmons Research Group Ltd.
  76. DePalma M, Slipman C: Managing osteoporotic vertebral compression fractures. J Musculoskel Med 22(9):445–454, 2005.
  77. Papapoulos SE: Paget’s disease of bone: clinical, pathogenetic, and therapeutic aspects. Baillieres Clin Endocrinol Metab 11(1):117–143, 1997. Medline abstracts
  78. Daroszewska A, Ralston SH: Genetics of Paget’s disease of bone. Clin Sci (London) 109(3):257–263, 2005. Medline abstracts
  79. Roodman GD, Windle JJ: Paget disease of bone. J Clin Invest 115(2):200–208, 2005. Medline abstracts
  80. American Academy of Orthopedic Surgeons: Paget’s disease of bone, Oct. 2005. Available online at: http://www.orthoinfo.aaos.org, (See tumors). Accessed January 21, 2011.
  81. Lydick E, Cook K, Turpin J, et al: Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Man Care 4:37–48, 1998.
  82. Elliott ME, Drinka PJ, Krause P, et al: Osteoporosis assessment strategies for male nursing home residents. Maturitas 48(3):225–233, July 2004.
  83. National Osteoporosis Foundation (NOF): Standing tall for you. Prevention: who’s at risk? Available online at http://www.nof.org. Accessed January 10, 2011.
  84. Orwoll ES, Bauer DC, Vogt TM, et al: Axial bone mass in older women. Ann Intern Med 124:187–196, 1996. Medline abstracts
  85. Funk D, Swank AM, Adam KJ, et al: Efficacy of moist heat pack application over static stretching on hamstring flexibility. J Strength Cond Res 15(1):123–126, 2001. Medline abstracts
  86. Daly MP, Berman BM: Rehabilitation of the elderly patient with osteoarthritis. Clin Geriatr Med 9:783–801, 1993. Medline abstracts
  87. Cottingham JT, Maitland J: A three-paradigm treatment model using soft tissue mobilization and guided movement-awareness techniques for a patient with chronic low back pain: a case study. J Orthop Sports Phys Ther 26(3):155–167, 1997. Medline abstracts
  88. Hayden JA, Van Tulder MW, Malmivaara AV, Koes BW: Meta-analysis: Exercise therapy for non-specific low back pain. Ann Intern Med 142(9):765–775, 2005. Medline abstracts
  89. Heggeness MH: Spinal fracture with neurological deficit in osteoporosis. Osteoporos Int 3(4):215–221, 1993. Medline abstracts
  90. D’Costa H, George G, Parry M, et al: Pitfalls in the clinical diagnosis of vertebral fractures: a case series in which posterior midline tenderness was absent. Emerg Med J 22:330–332, 2005. Medline abstracts
  91. Nevitt MC, Ettinger B, Black DM, et al: The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128(10):793–800, 1998. Medline abstracts
  92. Fink HA, Milaetz DL, Palermo L, et al: What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res 20(7):1216–1222, 2005. Medline abstracts
  93. The WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843, Geneva, 1994, World Health Organization.